BCAB logo

BioAtla, Inc. (BCAB)

Profile

Full Name

BioAtla, Inc.

Ticker

NASDAQ: BCAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 16, 2020

Indexes

Not included

Website

https://www.bioatla.com

Employees

61

Key Details

Price

$0.61(+13.78%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.00M(+100.00% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.61
    BCAB price is $0.61

    30-Day Relative Volume

    3.38
    BCAB 30-day relative volume is 3.38

    Price Performance

    Price Most recent change

    +13.78%
    BCAB price was up +13.78% on Sep 8, 2025

    Price YTD change

    +3.38%
    BCAB price is up +3.38% since January 1st

    Price 1-year change

    -66.43%
    BCAB price is down -66.43% year-on-year

    Price 3-year change

    -93.1%
    BCAB price is down -93.1% over the past 3 years

    Price Range

    Price All-time high

    $76.63
    BCAB price is currently -99.20% below its historical high of $76.63

    Price 3-year low

    $0.24
    BCAB price is currently +154.58% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $35.88M
    BCAB market capitalization is $35.88 million

    Market cap 3-year change

    -89.19%
    BCAB market capitalization is down -89.19% over the past 3 years

    Market cap All-time high

    $2.39B
    BCAB market capitalization is currently -98.50% below its historical high of $2.39 billion

    Market cap sector rank

    28.55%
    BCAB market capitalization is higher than 28.55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +21.49%
    BCAB shares outstanding is up +21.49% year-on-year

    Shares Outstanding 3-Year Change

    +56.52%
    BCAB shares outstanding is up +56.52% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.70
    BCAB beta is 1.70

    200-day SMA

    $0.54
    BCAB price is currently +12.46% above its 200-day simple moving average

    50-day SMA

    $0.39
    BCAB price is currently +56.63% above its 50-day simple moving average

    RSI

    78.00
    BCAB 14-day relative strength index is 78.00

    Volume

    3.38
    BCAB 30-day relative volume is 3.38

    ATR

    $0.04
    BCAB average true range is $0.04

    10-day Historical Volatility

    108.42%
    BCAB 10-day historical volatility is 108.42%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $11.00M
    BCAB annual revenue is $11.00 million

    Revenue Analysts estimate

    -
    BCAB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +100%
    BCAB annual revenue is up +100% year-on-year

    Revenue Sector rank

    49.42%
    BCAB annual revenue is higher than 49.42% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    BCAB annual earnings per share is $0.00

    EPS Analysts estimate

    -$1.19
    BCAB annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    BCAB annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.44%
    BCAB annual earnings per share is higher than 82.44% of companies in Healthcare sector

    Profit

    Gross profit

    $10.07M
    BCAB annual gross profit is $10.07 million

    Gross margin

    91.59%
    BCAB annual gross profit margin is 91.59%

    Operating profit

    -$73.94M
    BCAB annual operating income is -$73.94 million

    Operating margin

    -672.21%
    BCAB annual operating profit margin is -672.21%

    Net income

    -$69.78M
    BCAB annual net profit is -$69.78 million

    Net margin

    -634.33%
    BCAB annual net profit margin is -634.33%

    Expenses

    Total expenses

    $84.94M
    BCAB annual total expenses is $84.94 million

    Operating expenses

    $84.94M
    BCAB annual total operating expenses is $84.94 million

    Cost of goods sold

    $925.00K
    BCAB annual cost of goods sold is $925.00 thousand

    Selling, general & administrative expenses

    $21.85M
    BCAB annual SGA is $21.85 million

    Depreciation and amortization

    $925.00K
    BCAB annual depreciation & amortization is $925.00 thousand

    Interest expense

    $0.00
    BCAB annual interest expense is $0.00

    Income tax

    $0.00
    BCAB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$73.94M
    BCAB annual earnings before interest & taxes is -$73.94 million

    EBITDA

    -$73.02M
    BCAB annual EBITDA is -$73.02 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $52.42M
    BCAB annual total assets is $52.42 million

    Non current assets

    $1.19M
    BCAB annual long term assets is $1.19 million

    Current assets

    $51.23M
    BCAB annual total current assets is $51.23 million

    Cash and cash equivalents

    $49.05M
    BCAB annual cash & cash equivalents is $49.05 million

    Accounts receivable

    -
    BCAB annual accounts receivable value is unknown

    Inventory

    $0.00
    BCAB annual inventory is $0.00

    Liabilities

    Total liabilities

    $38.16M
    BCAB annual total liabilities is $38.16 million

    Long term liabilities

    $23.62M
    BCAB annual total long term liabilities is $23.62 million

    Current liabilities

    $14.54M
    BCAB annual total current liabilities is $14.54 million

    Accounts payable

    $1.90M
    BCAB annual accounts payable is $1.90 million

    Debt

    Total debt

    $836.00K
    BCAB annual total debt is $836.00 thousand

    Total debt 1-year change

    -66.02%
    BCAB annual total debt is down -66.02% year-on-year

    Long term debt

    $0.00
    BCAB annual long term debt is $0.00

    Short term debt

    $836.00K
    BCAB annual short term debt is $836.00 thousand

    Equity & Capital

    Shareholders equity

    $14.27M
    BCAB annual stockholders equity is $14.27 million

    Book value

    $14.27M
    BCAB annual book value is $14.27 million

    Retained earnings

    -$486.04M
    BCAB annual retained earnings is -$486.04 million

    Working capital

    $36.69M
    BCAB annual working capital is $36.69 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$71.94M
    BCAB annual cash flow from operations is -$71.94 million

    Cash from operations 1-year change

    +30.84%
    BCAB annual cash flow from operations is up +30.84% year-on-year

    Cash from investing

    $0.00
    BCAB annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    +100%
    BCAB annual cash flow from investing activities is up +100% year-on-year

    Cash from financing

    $9.51M
    BCAB annual cash flow from financing activities is $9.51 million

    Cash from financing 1-year change

    +12251.95%
    BCAB annual cash flow from financing activities is up +12251.95% year-on-year

    CAPEX

    CAPEX

    $0.00
    BCAB annual capital expenditures is $0.00

    CAPEX 1-year change

    -100%
    BCAB annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free cash flow

    -$71.94M
    BCAB annual free cash flow is -$71.94 million

    Free cash flow 1-year change

    +30.91%
    BCAB annual free cash flow is up +30.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    91.59%
    BCAB annual gross profit margin is 91.59%

    Operating margin

    -672.21%
    BCAB annual operating profit margin is -672.21%

    Net margin

    -634.33%
    BCAB annual net profit margin is -634.33%

    ROA & ROE

    ROA

    -81.10%
    BCAB annual return on assets is -81.10%

    ROE

    -164.30%
    BCAB annual return on equity is -164.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BCAB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BCAB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -2.14
    BCAB price to book ratio is -2.14

    PB ratio Sector rank

    8.67%
    BCAB price to book ratio is higher than 8.67% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.26
    BCAB price to sales ratio is 3.26

    PS ratio Sector rank

    46.53%
    BCAB price to sales ratio is higher than 46.53% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $23.72M
    BCAB enterprise value is $23.72 million

    Enterprise value Sector rank

    29.9%
    BCAB enterprise value is higher than 29.9% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.38
    BCAB EV/EBITDA is -0.38

    EV/EBITDA Sector rank

    56.08%
    BCAB EV/EBITDA is higher than 56.08% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.52
    BCAB annual current ratio is 3.52

    Quick ratio

    3.52
    BCAB annual quick ratio is 3.52

    Leverage

    Debt to equity

    0.00
    BCAB annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    BCAB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BCAB piotroski f-score value is unknown

    Altman Z-Score

    -16.02
    BCAB altman z-score is -16.02

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 JMP Securities
    Market Perform
    Mar 31, 25 HC Wainwright & Co.
    Neutral
    Mar 31, 25 Citizens Capital Markets
    Market Outperform
    Nov 13, 24 HC Wainwright & Co.
    Neutral
    Sep 16, 24 JMP Securities
    Market Outperform
    May 23, 24 JMP Securities
    Market Outperform
    May 15, 24 HC Wainwright & Co.
    Buy
    Mar 28, 24 JMP Securities
    Market Outperform
    Mar 27, 24 HC Wainwright & Co.
    Buy
    Dec 5, 23 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with BCAB included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for BioAtla, Inc.?
    • Does BioAtla, Inc. pay dividends?
    • What sector is BioAtla, Inc. in?
    • What industry is BioAtla, Inc. in?
    • What country is BioAtla, Inc. based in?
    • When did BioAtla, Inc. go public?
    • Is BioAtla, Inc. in the S&P 500?
    • Is BioAtla, Inc. in the NASDAQ 100?
    • Is BioAtla, Inc. in the Dow Jones?
    • When was BioAtla, Inc.'s last earnings report?
    • When does BioAtla, Inc. report earnings?

    What is the ticker symbol for BioAtla, Inc.?

    The ticker symbol for BioAtla, Inc. is NASDAQ:BCAB

    Does BioAtla, Inc. pay dividends?

    No, BioAtla, Inc. does not pay dividends

    What sector is BioAtla, Inc. in?

    BioAtla, Inc. is in the Healthcare sector

    What industry is BioAtla, Inc. in?

    BioAtla, Inc. is in the Biotechnology industry

    What country is BioAtla, Inc. based in?

    BioAtla, Inc. is headquartered in United States

    When did BioAtla, Inc. go public?

    BioAtla, Inc.'s initial public offering (IPO) was on December 16, 2020

    Is BioAtla, Inc. in the S&P 500?

    No, BioAtla, Inc. is not included in the S&P 500 index

    Is BioAtla, Inc. in the NASDAQ 100?

    No, BioAtla, Inc. is not included in the NASDAQ 100 index

    Is BioAtla, Inc. in the Dow Jones?

    No, BioAtla, Inc. is not included in the Dow Jones index

    When was BioAtla, Inc.'s last earnings report?

    BioAtla, Inc.'s most recent earnings report was on August 7, 2025

    When does BioAtla, Inc. report earnings?

    The next expected earnings date for BioAtla, Inc. is November 6, 2025
    On this page